Literature DB >> 4588545

Effect of imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno) on immunity in patients with malignant melanoma.

H W Bruckner, M B Mokyr, M S Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4588545

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.

Authors:  M S Mitchell; M B Mokyr; J M Davis
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

2.  Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.

Authors:  S Müller; T M Ernst
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

3.  [Veno-occlusive syndrome with acute liver dystrophy following decarbazine therapy of malignant melanoma (author's transl)].

Authors:  H Voigt; J Caselitz; M Jänner
Journal:  Klin Wochenschr       Date:  1981-03-02

4.  Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study.

Authors:  G A Currie; T J McElwain
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640

5.  Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines.

Authors:  Madhusudhanan Narasimhan; Lenin Mahimainathan; Andrew E Clark; Amena Usmani; Jing Cao; Ellen Araj; Fernando Torres; Ravi Sarode; Vaidehi Kaza; Chantale Lacelle; Alagarraju Muthukumar
Journal:  Vaccines (Basel)       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.